From Process Development to Prototype Manufacturing: How UMC7300 Supports Cardiovascular Medical Device Lab Workflows

Moving a drug-coated cardiovascular device from an early idea to a well-characterised prototype takes more than a coating trial. Teams need a repeatable workflow that links formulation decisions, equipment setup, sample handling, analytical evidence and design changes. An Ultrasonic Balloon Catheter Coating System such as the UMC7300 can support laboratory research, process development, optimisation and prototype production for projects involving balloon catheters and coronary stents.

In these programmes, paclitaxel-based coatings may be studied for balloon catheters and limus-based coatings for coronary stents. Each combination of drug formulation, substrate and device geometry should be treated as its own development case, with appropriate scientific and quality oversight.

Stage 1: Feasibility and requirements definition

Begin by translating the device concept into testable questions. Identify the substrate, coated region, target geometry, formulation constraints and the attributes that matter for the intended application. Establish how each attribute will be assessed before producing prototypes. This early definition helps avoid collecting attractive but inconclusive samples.

Build a sample and test plan

Set out sample quantities, labels, controls, inspection methods and the decision criteria for continuing or stopping a trial. Include a record of formulation batches and equipment configurations. The plan should reflect the development stage and the capabilities of the laboratory.

Stage 2: Formulation and process screening

During screening, investigate the interaction between formulation properties and deposition conditions. Factors may include formulation consistency, delivery settings, part positioning, motion, pass sequence and drying. Select factors based on a rationale, change them systematically and keep records that make comparisons possible. Avoid assuming a single coating recipe is appropriate for both balloons and stents.

Stage 3: Characterisation and design feedback

Use the results to identify where the process or device design may need refinement. For example, local accumulation can prompt a review of positioning or pass sequence; poor coverage can lead to an investigation of wetting, formulation properties or access to the target surface. The interpretation should be supported by suitable imaging or analytical data, not visual impressions alone.

Stage 4: Prototype build and repeatability checks

Once a promising condition has been identified, prepare representative prototypes and repeat selected runs. Confirm that the documented setup can be followed and that measured attributes remain within the project’s predefined criteria. Maintain traceability between each sample and the process conditions used to produce it.

Stage 5: Transfer planning and validation readiness

Before moving toward a manufacturing environment, review process risks, equipment requirements, operator instructions, material controls and measurement methods. Prototype success does not establish commercial readiness. Device-specific validation, risk management, biocompatibility, stability, sterilisation compatibility and regulatory evidence must be planned separately as applicable.

Cheersonic provides information about its ultrasonic drug balloon coating machine. Learn more about the underlying process family on the ultrasonic atomizing coating page.

How a lab coating platform supports cross-functional work

Coating development often involves formulation scientists, process engineers, device designers, analytical specialists and quality teams. A clearly documented laboratory workflow gives these groups a shared reference for comparing samples and discussing trade-offs. It also helps separate a formulation issue from a fixture, handling or process-control issue.

Frequently asked questions

1. Is prototype production the same as manufacturing validation?

No. Prototype production supports design and process learning. Validation requires a separate, documented programme with appropriate acceptance criteria and evidence.

2. What should be included in a prototype record?

Include device and sample identifiers, material details, formulation batch, equipment setup, process settings, handling history, inspection methods and results.

3. Can the same workflow be used for balloon and stent projects?

The project-management framework can be shared, but technical methods and acceptance criteria need to reflect the different geometries and drug-formulation requirements.

4. When should a laboratory involve quality and regulatory specialists?

Early in development. Their input can help ensure that records, risk assessments, test methods and later transfer plans are appropriate to the intended device and market.

Discuss your medical-device coating workflow

Qualified medical-device manufacturers, R&D teams and production engineers can contact Cheersonic to discuss their coating project and arrange a sample coating test. Email market2@cheersonic.com and include the device type, project stage and key questions you want the coating study to answer.